Position in PAHC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,299,960
-$917,971 QoQ
Shares Held
41,400
+3.2% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 207 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. PAHC ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,121,700 | $139,643,196 | |
| 2 | ZTS |
Zoetis Inc.
|
1,186,032 | $85,228,259 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
111,255 | $60,281,296 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
268,900 | $45,320,406 | |
| 5 | VTRS |
Viatris Inc
|
2,336,402 | $37,102,063 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,001,992 | $24,659,023 | |
| 7 | ALKS |
Alkermes plc.
|
316,900 | $16,605,560 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
130,654 | $14,494,754 |
All Filings in PAHC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,299,960 | 41,400 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,217,931 | 40,100 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,498,136 | 40,100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,594,124 | 39,400 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $990,952 | 38,800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $856,536 | 40,100 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $842,100 | 40,100 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $903,052 | 40,100 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $672,477 | 40,100 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $518,493 | 40,100 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $464,358 | 40,100 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $560,603 | 43,900 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $601,430 | 43,900 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $672,548 | 43,900 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $645,021 | 48,100 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $639,249 | 48,100 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $920,153 | 48,100 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $959,595 | 48,100 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $912,774 | 44,700 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $962,838 | 44,700 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,290,936 | 44,700 | Shares | Sole | 2021-08-06 | |
| 2020-12-31 | $877,784 | 45,200 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $786,480 | 45,200 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,187,404 | 45,200 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $949,881 | 39,300 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||